azacitidine and Lymphohistiocytosis, Hemophagocytic

azacitidine has been researched along with Lymphohistiocytosis, Hemophagocytic in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Aoyagi, T; Daitoku, S; Kuroiwa, M; Tada, S; Takao, S1
Bauer, F; Bilgrami, S; Boruchov, A; Mulay, S1

Other Studies

2 other study(ies) available for azacitidine and Lymphohistiocytosis, Hemophagocytic

ArticleYear
Successful Treatment of Hemophagocytic Lymphohistiocytosis Associated with Low-risk Myelodysplastic Syndrome by Azacitidine.
    Internal medicine (Tokyo, Japan), 2018, Oct-15, Volume: 57, Issue:20

    Topics: Aged; Antimetabolites, Antineoplastic; Asian People; Azacitidine; Hematologic Neoplasms; Humans; Lymphohistiocytosis, Hemophagocytic; Lymphoma; Male; Myelodysplastic Syndromes; Treatment Outcome

2018
Successful resolution of acute myelogenous leukemia-associated hemophagocytic lymphohistiocytosis with decitabine.
    Leukemia & lymphoma, 2011, Volume: 52, Issue:2

    Topics: Aged; Antimetabolites, Antineoplastic; Azacitidine; Decitabine; Humans; Leukemia, Myeloid, Acute; Lymphohistiocytosis, Hemophagocytic; Male; Treatment Outcome

2011